NCT02714790View on ClinicalTrials.gov

Prognostic Role of Minimal Residual Disease in Acute Myeloid Leukemia

CompletedOBSERVATIONAL
Enrollment

281

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions
Acute Myeloid LeukemiaMinimal Residual DiseaseWilms Tumor
All Listed Sponsors
lead

A.O.U. Città della Salute e della Scienza

OTHER

NCT02714790 - Prognostic Role of Minimal Residual Disease in Acute Myeloid Leukemia | Biotech Hunter | Biotech Hunter